| 000 | 00000nam##2200000za#4500 |
| 001 | 9.671207 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210615130024 |
|---|
| 007 | ta |
|---|
| 008 | 150407|2009||||xxc||||| f|0| 0 eng|d |
|---|
| 020 | |a978-0-662-06718-4 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 041 | |aeng |
|---|
| 041 | |afre |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP35-11/2009 |
|---|
| 110 | 2 |aPublic Health Agency of Canada. |
|---|
| 245 | 10|aPerformance monitoring for cervical cancer screening programs in Canada |
|---|
| 260 | |bPublic Health Agency of Canada |cJanuary 2009. |
|---|
| 300 | |aEnglish text, 37p. : |bfig., glossary, references, tables ; |c28 cm. |
|---|
| 500 | |a"Collaboration with Cervical Cancer Prevention & Control Network (CCPCN)" |
|---|
| 520 | 3 |aDefines a core set of performance indicators for organized cervical cancer screening programs in Canada. Establishing a pan-Canadian set of performance indicators will provide a means to monitor the performance of the various components of the screening process, and facilitate inter-jurisdictional comparisons. Over time, with the regular monitoring and reporting of these indicators, an evidence base will grow which will permit the setting of pan-Canadian targets and provide the baseline data required to evaluate the impact of new diagnostic technologies such as HPV testing and interventions, for example, the HPV vaccine. |
|---|
| 563 | |aSoftcover |
|---|
| 590 | |a09-45|b2009-11-06 |
|---|
| 690 | 07|aCancer|2gcpds |
|---|
| 776 | 0#|tSurveillance du rendement des programmes de dépistage du cancer du col utérin au Canada |w(CaOODSP)9.636361 |
|---|
| 776 | 0#|tPerformance monitoring for cervical cancer screening programs in Canada |w(CaOODSP)9.692110 |
|---|
| 792 | |tSurveillance du rendement des programmes de dépistage du cancer du col utérin au Canada |efre|w(CaOODSP)9.671208 |
|---|